paraformaldehyde phosphate buffer solution (Nacalai)
86
Structured Review
Nacalai
paraformaldehyde phosphate buffer solution
Paraformaldehyde Phosphate Buffer Solution, supplied by Nacalai, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphate+buffer+solution/buffer+paraformaldehyde+phosphate+solution/pm42321187-525-11-15
Average 86 stars, based on 1 article reviews
Paraformaldehyde Phosphate Buffer Solution, supplied by Nacalai, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphate+buffer+solution/buffer+paraformaldehyde+phosphate+solution/pm42321187-525-11-15
Average 86 stars, based on 1 article reviews
paraformaldehyde phosphate buffer solution - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Extracellular Microvesicles Modified with Arginine-Rich Peptides for Active Macropinocytosis Induction and Delivery of Therapeutic Molecules. Article Snippet: Extracellular vesicles (EVs), including exosomes and microvesicles (MVs), transfer bioactive molecules from donor to recipient cells in various pathophysiological settings, thereby mediating intercellular communication.. Despite their significant roles in extracellular signaling, the cellular uptake mechanisms of different EV subpopulations remain unknown.. In particular, plasma membrane-derived MVs are larger vesicles (100 nm to 1 μm in diameter) and may serve as efficient molecular delivery systems due to their large capacity; however, because of size limitations, receptor-mediated endocytosis is considered an inefficient means for cellular MV uptake. Article Title: Synthesis of Oligodeoxynucleotide Containing Pseudo‐Deoxycytidine and Its Triphosphate Derivative Article Snippet: 15 μl of 1 M magnesium chloride (MgCl) (Wako Pure Chemical, cat. no. 310‐90361), 15 mM final 100 μl of 100 mM Dissolution:Article Title: Role of Amyloid Nanofibrils in Drug Incorporation and Release from Wrinkled Supraparticles Article Snippet: Nanoparticle aggregates, termed supraparticles (SPs), exhibit a range of promising properties.. In the pharmaceutical field, changing the type or ratios of the building blocks that constitute the SP may alter the SP morphology but also significantly improve its function as a drug delivery carrier or biomaterial.. Our previous work demonstrated that wrinkled SPs can be prepared by incorporating amyloid nanofibrils (ANFs) into the spray-drying precursor. Recombinant:Article Title: Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof Article Snippet: .. Specifically, a solution in which the human BMP10 recombinant prepared in Example 1, 1-1) or a human BMP10 mature dimer (manufactured by R & D Systems, Inc., Cat #2926-BP) was prepared at 0.5 μg/mL with a Enzyme-linked Immunosorbent Assay:Article Title: Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof Article Snippet: .. Specifically, a solution in which the human BMP10 recombinant prepared in Example 1, 1-1) or a human BMP10 mature dimer (manufactured by R & D Systems, Inc., Cat #2926-BP) was prepared at 0.5 μg/mL with a Adsorption:Article Title: Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof Article Snippet: .. Specifically, a solution in which the human BMP10 recombinant prepared in Example 1, 1-1) or a human BMP10 mature dimer (manufactured by R & D Systems, Inc., Cat #2926-BP) was prepared at 0.5 μg/mL with a Blocking Assay:Article Title: Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof Article Snippet: .. Specifically, a solution in which the human BMP10 recombinant prepared in Example 1, 1-1) or a human BMP10 mature dimer (manufactured by R & D Systems, Inc., Cat #2926-BP) was prepared at 0.5 μg/mL with a Activity Assay:Article Title: Synthesis of Oligodeoxynucleotide Containing Pseudo-Deoxycytidine and Its Triphosphate Derivative. Article Snippet: .. REAGENTS AND SOLUTIONS Denaturing polyacrylamide gel, 20% (w/v) 37.5 ml of 40% (w/v) acrylamide/bis mixed solution (19:1) (Nacalai, cat. no. 06140-45), 20% (w/v) final 7.5 ml Tris-borate-EDTA buffer (Nacalai, cat. no. 35440-31) 31.5 g urea (Nacalai, cat. no. 35907-44), 7 M final 7.5 ml ddH2O Store up to 1 year at room temperature Melting temperature buffer, 2× 15 μl of 1 M magnesium chloride (MgCl) (Wako Pure Chemical, cat. no. 310-90361), 15 mM final 100 μl of 100 mM |